Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Insulin Formulations: Types and Delivery

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Insulin: Dosing Regimen and Adverse Effects

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

Insulin: Biosynthesis, Chemistry, and Preparation

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...

Diabetes Mellitus: Introduction

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...

Oral Drug Delivery Systems: Continuous-Release Systems

Oral Drug Delivery Systems: Continuous-Release Systems

Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Participants' experiences of living with cystic fibrosis related diabetes and using a hybrid closed-loop system to support self-management: qualitative study.

BMC endocrine disorders·2026

Same author

Hypoglycaemia Was Not Associated With Depression, Anxiety, Diabetes Distress or Fear of Hypoglycaemia Scores in People With Type 1 or Insulin-Treated Type 2 Diabetes in the Hypo-METRICS Study.

Diabetes, obesity & metabolism·2026

Same author

Cambridge hybrid closed-loop use in very young children with type 1 diabetes: Parental expectancies during long-term home use.

Diabetic medicine : a journal of the British Diabetic Association·2026

Same author

Automated Insulin Delivery: Great Strides in the Past, Great Needs for the Future.

Diabetes care·2026

Same author

Gold and Clarke Questionnaires Identify Different People With Insulin-Treated Diabetes and Impaired Awareness of Hypoglycaemia in Almost 60% of Cases: A Post Hoc Analysis From the Hypo-METRICS Study.

Diabetes, obesity & metabolism·2026

Same author

Continuous glucose monitoring versus self-monitoring of blood glucose in individuals with type 2 diabetes: a randomised, multicentre, open-label, superiority trial.

The lancet. Diabetes & endocrinology·2026

Search research articles

Related Experiment Video

Updated: May 24, 2026

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Closed-loop insulin delivery: towards improved diabetes care.

Kavita Kumareswaran¹, Mark L Evans, Roman Hovorka

¹Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Centre, Institute of Metabolic Science, University of Cambridge, Cambridge, CB2 0QQ, United Kingdom.

Discovery Medicine

|February 29, 2012

Summary

Type 1 diabetes management is improving with artificial pancreas technology. Closed-loop insulin delivery systems show promise in controlling blood glucose and reducing hypoglycemia risk, paving the way for wider clinical use.

More Related Videos

Intra-Omental Islet Transplantation Using h-Omental Matrix Islet filliNG (hOMING)

Intra-Omental Islet Transplantation Using h-Omental Matrix Islet filliNG (hOMING)

Published on: March 14, 2019

Related Experiment Videos

Last Updated: May 24, 2026

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Intra-Omental Islet Transplantation Using h-Omental Matrix Islet filliNG (hOMING)

Intra-Omental Islet Transplantation Using h-Omental Matrix Islet filliNG (hOMING)

Published on: March 14, 2019

Area of Science:

Endocrinology
Biomedical Engineering
Diabetes Technology

Background:

Type 1 diabetes prevalence is rising globally, necessitating advanced treatment strategies.
Conventional insulin therapy faces limitations due to hypoglycemia risks and daily glycemic variability.
Technological advancements offer new hope for improved diabetes management.

Purpose of the Study:

To evaluate the potential of artificial pancreas (closed-loop insulin delivery) systems in managing type 1 diabetes.
To assess the efficacy of closed-loop systems in improving glucose control and reducing hypoglycemia.
To identify current limitations and future directions for closed-loop insulin delivery systems.

Main Methods:

Utilizing continuous glucose monitoring (CGM) integrated with insulin pump therapy.
Developing and testing closed-loop insulin delivery prototypes under controlled settings.
Analyzing data on glucose control metrics and hypoglycemia events.

Main Results:

Closed-loop prototypes demonstrated improved glycemic control compared to conventional methods.
A significant reduction in the risk of hypoglycemia was observed with closed-loop systems.
Current limitations include CGM accuracy and subcutaneous insulin delivery delays.

Conclusions:

Artificial pancreas technology holds significant promise for enhancing type 1 diabetes care.
Further research and development are needed to overcome current technological limitations.
Outpatient evaluations are crucial for advancing closed-loop systems toward clinical practice.